Life Sciences

ORI shares a Natick office with AffyImmune Therapeutics, a company in ORI’s portfolio that received $30 million from the firm in 2021.

Bruning, who has served on StageBio’s board of directors for the previous five years, has more than 25 years of experience with companies providing preclinical testing services.

Marlborough medical technology firm Boston Scientific has received approval from the U.S. Food and Drug Administration for its WaveWriter Alpha spinal cord stimulator device to be used to treat low back and leg pain deriving from a condition referred to as non-surgical back pain. 

The filing didn’t specify where or when the layoffs would take place, except they are part of a restructuring of its diagnostics division, which has been losing money due to a drop in sale of COVID tests.

In the wake of a survey showing manufacturing companies are losing confidence in the state’s current business climate, the North Central Massachusetts Chamber of Commerce has launched the Manufacturing Council of North Central Massachusetts in an effort to enhance the organization’s support of the industry.

The situation in Central Massachusetts, where 15.6% of named executive officers are female, largely mirrors the Massachusetts rate of 16.1% determined in a statewide census.

Though the name of the client and the cancer treatment it produces is confidential, Rentschler Biopharma's Tom Roberts says this is just the first in a new wave of business in Milford for the 150-year-old company. 

The company said the rebranding was made to reflect the growth and evolution of the 23-year old firm.

Acton medical device manufacturer Insulet has made a number of changes to its board, including the retirement of its former leader.

ReWalk is expanding direct sales of its exoskeleton devices into Canada.